Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed May 14, 2013 · 10-Q · 44 days after period end · 0001054102-13-000011
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $42.92M | $31.68M | $44.30M |
| Net Income | $2.13M | -$272.00K | -$550.00K |
| EPS Diluted | $0.14 | -$0.02 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 14, 2013 · 44 d after period end
